These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 8203779

  • 1. At the crossroads of venous insufficiency and hemorrhoidal disease: Daflon 500 mg--repercussions of venous insufficiency on everyday life.
    Launois R.
    Angiology; 1994 Jun; 45(6 Pt 2):495-504. PubMed ID: 8203779
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Advantage of a micronized flavonoidic fraction (Daflon 500 mg) in comparison with a nonmicronized diosmin.
    Amato C.
    Angiology; 1994 Jun; 45(6 Pt 2):531-6. PubMed ID: 8203783
    [Abstract] [Full Text] [Related]

  • 5. At the Crossroads of Venous Insufficiency and Hemorrhoidal Disease: Daflon 500 mg. Proceedings of a symposium. Vienna, Austria, January 31, 1992.
    Angiology; 1994 Jun; 45(6 Pt 2):493-584. PubMed ID: 7911285
    [No Abstract] [Full Text] [Related]

  • 6. [The drug therapy of chronic venous insufficiency (a trial of the clinical use of the preparation Detralex)].
    Iablokov EG, Bogachev VIu, Domoradskaia AI.
    Ter Arkh; 1996 Jun; 68(10):80-1. PubMed ID: 9026954
    [Abstract] [Full Text] [Related]

  • 7. Techniques used to evaluate the cutaneous microcirculation: application of photoplethysmography to the assessment of a phlebotropic agent in the treatment of leg ulcers.
    Guillot B.
    Angiology; 1994 Jun; 45(6 Pt 2):542-8. PubMed ID: 8203785
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Flavonoids. A review of the pharmacology and therapeutic efficacy of Daflon 500 mg in patients with chronic venous insufficiency and related disorders.
    Struckmann JR, Nicolaides AN.
    Angiology; 1994 Jun; 45(6):419-28. PubMed ID: 8203767
    [Abstract] [Full Text] [Related]

  • 12. [Clinical evaluation of a new drug in phlebology].
    Spartera C, Santoro P, Frezzotti A, Marciani A, Ricci G.
    Clin Ter; 1979 Jan 31; 88(2):139-47. PubMed ID: 428194
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Are the phlebotonic properties shown in clinical pharmacology predictive of a therapeutic benefit in chronic venous insufficiency? Our experience with Daflon 500 mg.
    Tsouderos Y.
    Int Angiol; 1989 Jan 31; 8(4 Suppl):53-9. PubMed ID: 2698902
    [Abstract] [Full Text] [Related]

  • 15. [Edema as a measure for severity of chronic venous insufficiency and efficacy of its treatment].
    Sapelkin SV.
    Angiol Sosud Khir; 2008 Jan 31; 14(3):79-81. PubMed ID: 19791434
    [Abstract] [Full Text] [Related]

  • 16. [Trial of Daflon in ano-rectal and lower limb venous pathology. Apropos of 59 treated cases].
    Thanh LH.
    Phlebologie; 1973 Jan 31; 26(3):433-40. PubMed ID: 4790987
    [No Abstract] [Full Text] [Related]

  • 17. Clinical evaluation of a venotropic drug in man. Example of Daflon 500 mg.
    Laurent R, Gilly R, Frileux C.
    Int Angiol; 1988 Jan 31; 7(2 Suppl):39-43. PubMed ID: 3053942
    [Abstract] [Full Text] [Related]

  • 18. Venous elasticity after treatment with Daflon 500 mg.
    Ibegbuna V, Nicolaides AN, Sowade O, Leon M, Geroulakos G.
    Angiology; 1997 Jan 31; 48(1):45-9. PubMed ID: 8995343
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.